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Following the Food and Drug Administration approval, robot-assisted colorectal surgery has gained more 
acceptance among surgeons. One of the open issues about robotic surgery is the economic sustainability. The 
aim of our study is to evaluate the economic sustainability of robotic as compared to laparoscopic right 
colectomy for the Italian National Health System. 
Methods 
We performed a retrospective multicentre case-matched study including 94 patients for each group from four 
different Italian surgical departments. An economic evaluation gathered from a real world data was performed 
to assess the sustainability of the robotic approach for right colectomy in the Italian National Health System. 
In particular, a differential cost analysis between the two procedures was performed. 
Results 
No statistical differences were found between the two groups for postoperative outcomes. After a careful 
review of the literature on the cost assessment for the operative room, medical devices and hospital stay 
according with our data, we estimated the followings: (a) the mean operative room cost for robotic group was 
2179 .  for laparoscopic group; (b) the mean hospital stay cost for robotic group was 
3143  1435 . 3292  1123 laparoscopic group; (c) the mean cost for instruments was 6280 
robotic group vs. 1504 laparoscopic group. The total mean cost of robotic right colectomy was 11,576 
1915 . olectomy. 
Conclusion 
In conclusion, to date, robotic right colectomy with intracorporeal anastomosis does not provide any significant 
clinical advantages, which may justify the additional costs, as compared to its laparoscopic counterpart. Further 
evolution of robotic technology and experience may lead to a reduction of costs, especially if the robotic 
platform is used in an appropriate healthcare setting. 





































































In the last decades, surgical technology has gone through a great evolution, especially in the minimally invasive 
field. Robot-assisted surgery represents a new trend in minimally invasive surgery and surgical literature.  
Nowadays, the minimally invasive approach represents the gold standard for many surgical procedures, for 
both benign and malignant diseases [1]. Although technically demanding, minimally invasive right colectomy 
with intracorporeal anastomosis may be the preferred approach for right colon cancer treatment. Several 
advantages including reduced short-term morbidity and faster recovery have been associated to intracorporeal 
as compared to extracorporeal anastomosis  [2, 3].  
Following the Food and Drug Administration approval, robot-assisted colorectal surgery has gained more 
acceptance among surgeons [4, 5]. In the field of colon surgery, the robotic approach has shown no significant 
benefits for patients as compared to the laparoscopic approach, but some advantages have been demonstrated 
for surgeons, including a better view of the operative field and a better instrument for precision and easiness 
of movement [6, 7]. Thus, robotic assistance could enhance the ability of the surgeon to perform a totally 
minimally invasive right colectomy with intracorporeal anastomosis. 
One of the critical issues about robotic surgery is the economic sustainability [6]. In fact, despite the advantages 
for the surgeon and the possibility to easily tutor more surgeons due to the dual console, further investigation 
is warranted when considering routine use of the robotic platform for colectomies [8].  
In our multicentre study, we performed a retrospective case-matched analysis of 94 patients who underwent 
robot-assisted right colectomy (RRC) compared with a group of patients who underwent laparoscopic right 
colectomy (LRC). The main aim of our study is to evaluate the economic sustainability of RRC as compared 
to LRC for the Italian National Health System. 
Materials and Methods 
After the ethical committee approval, all consecutive patients who underwent elective LRC or RRC for cancer 
from January 2012 to August 2017 at four Italian surgical departments (Department of General and Minimally 
Invasive Surgery, San Camillo Hospital, Trento; Department of Surgical Specialities and Nephrology, 
University of Naples Federico II; Department of Surgery, Division of General Surgery, Hospital of Arezzo; 
Department of Abdominal Surgery, Casa Sollievo della Sofferenza Research Hospital, San Giovanni Rotondo), 


































































Among these, 159 patients underwent LRC and 116 had RRC. In order to reduce the risk of bias due to the 
patient selection in the robotic group, we performed a case-matched analysis using the Mantel-Haenszel 
method. The two groups were matched according to their biometric features. After matching, a total of 188 
patients were analysed, namely 94 patients in each group. 
Preoperative (age, sex, BMI, previous abdominal surgery, ASA score and tumour location), intraoperative 
(operative time, complications, conversion rate) and postoperative (pathologic stage according to Wittekind et 
al. [9], length of specimen, number of harvested lymph nodes, postoperative return of bowel function, hospital 
stay, complications according to the Clavien-Dindo classification [10], reoperation and mortality rates) data 
were reviewed.  
Conversion was defined as the unplanned change from laparoscopy to the open procedure or from the robotic 
approach to either the laparoscopic or the open approach. Anastomotic leakage was considered along with all 
conditions with clinical or radiologic features of anastomotic dehiscence in accordance with the UK Surgical 
Infection Study Group [11]. We considered operative time as the time from the first skin incision until the last 
scar was sutured. 
All procedures in both groups were carried out by four highly experienced laparoscopic colorectal surgeons 
[12]. All surgeons had completed the learning curve of robotic colorectal surgery before the inclusion of cases 
in this series [13].  
Follow-up was conducted by a clinical examination at 7, 30, 180 days and then each year after surgery. 
Cost Analysis 
The differential cost analysis was conducted from an Italian hospital perspective, including medical costs (use 
of operating room, length of stay and medical devices) only, as performed in previous studies [14, 15], and 
from a National Health System (NHS)/Health care payer perspective.  
According to the existing literature [16], the differential cost analysis is widely used for healthcare decisions. 
In particular, differential cost analysis was used to assess the difference between the cost of two alternative 
decisions (RRC vs. LRC).  The concept is usually used when there are two or multiple possible options to 


































































The costing search was based on the economic assessment methodology adopted in Health Technology 
Assessment and was performed by two clinicians (UB and GM) and two biomedical engineers (RC and LP). 
Postoperative costs were also included in the cost analysis.  
To assess the cost of the two procedures from the hospital perspective, we considered the mean operative time, 
mean length of stay and mean cost of medical devices in both groups. According to our previous study, we 
estimated that the cost of  , 
respectively [14]. The cost of hospital stay also included the cost of both daily drugs and health staff.  We 
calculated the mean costs for medical devices (e.g., trocar) from the National Health Price List (NHPL) and as 
reported by Ho et al. [17].  
To evaluate the differential costs from the NHS perspective, we estimated that the mean reimbursement for 
right colectomy for cancer was 6838  900 , which was calculated performing the average reimbursement of 
Diagnosis Related Group (DRG) codes for each Italian region. These results did not consider the fixed 
maintenance costs of equipment, which are extremely variable in structure and must be distributed on the total 
amount of procedures performed. 
Statistical Analysis 
The statistical analysis was carried out using IBM SPSS Statistics 25. Continuous data were expressed as mean 
standard deviation (SD). To compare continuous variables, an independent sample T-test was performed. 
The Chi-square test was employed to analyse categorical data. Logistic regression was performed in order to 
understand if some factors could influence operative time or length of stay. Regarding non-parametric variables 
(such as time to flatus and length of stay), we used a Mann-Whitney U test.  
All the results are presented herein as 2-tailed values with statistical significance if the p-values were below 
0.05.  
Perioperative Management  
Mechanical bowel preparation was not administered, and no diet restriction was applied before surgery. 
Intravenous antibiotic prophylaxis was given to all patients. Antiemetics were administrated regularly for 72 
hours postoperatively. On the first postoperative day the patient could drink, if tolerated, and a normal diet was 
offered from day 2 onwards. Early mobilization and low molecular weight heparin were used for deep venous 


































































nonsteroidal anti-inflammatory drugs, if required. Discharge criteria included tolerance of oral intake, absence 
of nausea or vomiting, return of bowel function, absence of abdominal distention, no evidence of 
complications, adequate mobility, patient acceptance [14]. When a postoperative complication required 




was established with the Veress technique [19]. We used the same technique described in our previous study 
[12]. After abdominal exploration, in order to exclude the presence of metastases, the ileo-colic vessels were 
ligated and divided. A medial-to-lateral dissection was conducted between the  fascia and the 
fascia. If present, the right colic vessels were isolated and divided. Once the transverse colon was pulled up, 
its mesentery was dissected from the root and the right branches of the middle colic vessels were identified 
and divided. Then, we mobilized the right colon by dissecting the gastro-colic and parieto-colic ligaments. 
Complete division of the ileal mesentery allowed for full mobilization of the right colon. The transverse colon 
and terminal ileum were transected intracorporeally by a blue- and white-cartridge linear stapler, respectively. 
A side-to-side isoperistaltic ileo-colic anastomosis was performed by a 45-mm linear stapler with a blue 
cartridge. The enterotomy was closed with a double layer running suture [12, 20]. The mesentery was closed 
by absorbable sutures or fibrin glue. The specimen was retrieved through a Pfannenstiel incision or umbilical 
scar enlargement [21].  
RRC 
For the RRC, we performed the same technique described for the laparoscopic approach. Trocars  position is 
reported by Spinoglio et al. [22]. In the first 35 robotic cases, a Da Vinci Si surgical system was used, while a 
DaVinci Xi platform was used in the subsequent cases. 
Results 
We performed a case-matched analysis comparing two homogeneous group of 94 patients each. Patient 
features are reported in Table 1. 
Operative time was significantly longer for RRC than LRC (135.5  33.9 min in the LRC group vs. 207.5  


































































or postoperative complications and length of stay (4.2 1.4 days in the LRC group vs. 4.0 1.8 days in the 
RRC group, p = 0.475) between the two groups. Three cases in the RRC group required conversion to open 
surgery compared to none in the laparoscopic group (p = 0.080). They were all due to advanced colon cancer. 
As reported in Table 2, only 3 Clavien-Dindo III complications were recorded in each group. In particular, 
there were 2 anastomotic bleedings requiring endoscopic management and one anastomotic leakage in both 
groups.   
At the 30-day follow-up, there were neither reinterventions nor deaths, and only one readmission was recorded 
in the LRC group due to heart failure. At a mean follow-up of 51.7  12.6 months, 5 deaths were recorded, 
two in the RRC group and three in the LRC group. Logistic regression did not show any association between 
operative time or length of stay and the other variables analysed, including age, BMI, time to flatus and 
pathologic stage. 
After a careful review of the literature on the cost assessment for operative room, medical devices and hospital 
stay according with our data, we estimated the followings: (a) the mean operative room cost for the RRC group 
was 2179  476 vs. 1376  322  for the LRC group; (b) the mean hospital stay cost for the RRC group was 
3143  1435 vs. 3292  1123 for the LRC group; (c) the mean cost for instruments was 6280 for the RRC 
group vs. 1504 for the LRC group. The total mean cost of RRC was 11,576  1915  vs. 6196  1444 for 
LRC. Data from cost analysis are reported in Table 3.  
Discussion 
Over the last years, there has been a rapid increase in the use of the robotic approach to colorectal surgery, 
although the real benefits over laparoscopy in terms of outcomes still remain unclear [23, 24]. Thus, the 
adoption of robotic surgery must be examined against a backdrop of burdening an already expensive healthcare 
system [25].   
In our evaluation, we found that postoperative short-term outcomes of RRC and LRC performed with 
intracorporeal anastomosis are similar. To date, a few studies included intracorporeal anastomosis when 
comparing RRC and LRC. A recent retrospective multicentre analysis of 389 patients did not find any 
difference in terms of time-to-first flatus, postoperative complications and hospital stay, although RRC was 
associated with a lower 90-day readmission rate. In this series, LRC group comprised only 84 of 389 cases, 


































































is consistent with the results of a recent meta-analysis, which found a higher rate of intracorporeal anastomosis 
in the robotic group [26]. Indeed, the robotic platform decreases the difficulty of intracorporeal suturing [27]. 
Since intracorporeal anastomosis is associated with faster recovery and lower morbidity as compared to 
extracorporeal anastomosis, the use of the robotic approach aiming to increase the number of intracorporeal 
anastomosis may be advisable [23]. Moreover, for surgeons early in their career, robotic assistance may shorten 
the learning curve of minimally invasive right colectomy as compared to the laparoscopic approach [24]. 
In agreement with published studies, operative time was significantly longer in the RRC group also in this 
cohort. This could be due to the docking time, which may prolong the duration of the robotic procedure [23]. 
The learning curve effect has also been reported to play a role in increasing operative time. As in most 
published series, all surgeons involved in our study were more highly experienced in laparoscopic rather than 
robotic colorectal surgery, and this may have partially affected length of surgical time. However, they had 
completed the learning curve of robotic colorectal surgery at the beginning of the study. Although not analysed 
in our series, operative time may decrease over time, as the number of performed procedures increases. In a 
series of 101 procedures, a statistically significant difference was found between the earlier and the later robotic 
series (329 vs. 266 min). The authors also reported a significant reduction in the conversion rate, claiming a 
benefit in performing both dissection and intracorporeal anastomosis by robotic assistance [22]. This was not 
confirmed in the present study, where a significantly higher conversion rate was observed in the RRC group 
than in the LRC group. A more meticulous dissection of tissues has also been suggested as a potential reason 
for the increased duration of the robotic procedure [23].  
Pathologic outcomes were comparable between RRC and LRC. Some authors suggested that the number of 
harvested lymph nodes may be higher with robotic assistance [23]. Moreover, RRC appears to achieve similar 
long-term survival rates as compared with LRC [28]. 
Robot-assisted procedures are increasing since laparoscopic surgeons are incorporating robotics into their 
normal practice [25]. Experienced laparoscopic surgeons may be able to overcome  at least partly  the 
technical drawbacks of conventional laparoscopy and be equally proficient at both procedures [24]. In the 
future, it might be expected that a better robotic experience will show considerable clinical advantages of RRC 


































































Although the costs of RRC exceed those of LRC, data are still based on a limited number of procedures 
available from different health systems [26, 27]. In a meta-analysis of five studies, Solaini et al. found that the 
mean total cost was US $10,335 for LRC vs. US $12,299 for RRC (SMD  0.52, 95% CI  1 to  0.04, p = 
0.035). Moreover, based on the results of three studies, surgery-only related costs were higher in the robotic 
group ($5953 vs. $3930, SMD  2.8, 95% CI  5.53 to 0.02, p = 0.051) [26]. Indeed, the higher costs of RRC 
are primarily attributable to surgery, including consumables and longer operative times [28].  
A retrospective analysis of the 2012-2014 Healthcare Cost and Utilization Project-National Inpatient Sample 
(NIS) was recently conducted in the United States. In a cohort of 7685 colectomies, RRC was 20.1% more 
costly than LRC ($15,027  vs. $12,516 ), even if the length of stay was 4.3  2 in the laparoscopic 
group versus  in the robotic group. This may suggest that, to date, the additional costs related to robotic 
procedures are not compensated by the savings from shorter hospital stay. However, these costs may be lower 
in centres with higher volume cases, where more experienced surgeons and staffs can optimize the operating 
room time. Studies using costs from single hospital systems may be more informative for a detailed cost 
analysis as compared to national database analysis. In fact, the latter provides total charges for each admission 
but not the actual cost, and details of costs related to supplies and instruments are not reported [29]. Similarly, 
a matched analysis of 1066 patients from the Premier Hospital Database found significantly higher hospital 
costs and longer operative times in the robotic group, while length of stay was similar for both surgical 
approaches [8]. 
A review of a hospital cost-accounting database including 111 patients who underwent elective minimally 
invasive colectomy (18 robotic surgeons) over a 1-year period showed that the cost of robotic colectomy was 
53% greater than laparoscopic colectomy ($7806 vs.  No significant difference in overall 
costs between different surgeons was demonstrated despite varied training, experience levels and operative 
techniques. This demonstrates that total costs are relatively institutionally fixed and minimally influenced by 
variations in individual surgeon practice preferences [30]. There are no data about cost-analysis of RRC from 
the Italian healthcare system. The present evaluation from Italian centers found that RRC was nearly 70% 
more costly than LRC, and this increased cost was primary attributable to consumables, while the costs for 


































































robotic and laparoscopic systems should be also considered [31], and they were not included in the present 
analysis.   
A previous cost-analysis comparing laparoscopic versus open surgery for colorectal cancer in three Italian 
high-volume centres, found that the national DRG tariff is insufficient to remunerate the providers' activity, 
irrespective of the type of disease and surgical technique adopted [32]. This issue is even more compelling 
given the growing interest for robotic colorectal surgery. In our series, the mean reimbursement for right 
colectomy was 50% of total estimated costs for RRC. 
Our study includes comparison of equivalent surgical procedures in a quite large sample size population from 
different centres, with adequate follow-up. Although it is a retrospective study, a case-matched analysis has 
been performed in order to reduce the risk of bias due to the selection of patients in the robotic group.  
Some limitations should be considered. There is no full accounting for the costs of postoperative complications. 
However, the length of the hospital stay itself may be an indirect indicator of the increased cost of complicated 
patients. Furthermore, the incidence of complications  especially those requiring additional procedures and/or 
ICU management  was low and comparable between the two groups (3 vs. 3). Therefore, we considered that 
they did not significantly affect the differential cost analysis between the two procedures. Enhanced recovery 
after surgery (ERAS) protocols have been increasingly applied to colorectal surgery over the last years. As 
reported by many studies, such protocols seem to reduce drastically the economic impact of colorectal surgery, 
although the breakdowns of the costs and statistical methods are ambiguous and inconsistent among studies 
and institutions [33]. A structured enhanced recovery pathway has not been used in our cohort. Thus, the costs 
associated with implementing an ERAS program have not been evaluated. The perioperative care included 
only some items of the ERAS protocol and it has not significantly changed over the study period. Therefore, 
it did not impact on both length of stay and costs. According to the ERAS principles, the patients in this cohort 
did not receive preoperative MBP, although more recent evidence suggests that combination of MBP  and oral 
antibiotics can reduce the risk of surgical site infections [33].  
In conclusion, to date, RRC with intracorporeal anastomosis does not provide tangible benefits to the patients, 
which may justify the additional costs as compared to its laparoscopic counterpart. However, at a time when 
taking care of optimal resource utilization is essential, every effort should be made to support the development 


































































development of robotics may lead to reduction of costs and improvement of outcomes, as occurred in the past 
for laparoscopic surgery. Moreover, although it is beyond the evaluations of our paper, the robotic approach 
may be particularly effective to reduce the learning curve for young surgeons [35]. The advantages of robotic 
surgery can be better explored and developed in any institutions with additional resources and research 
mandate. Further prospective studies comparing both surgical approaches with cost analysis are needed to 
draw robust conclusions. 
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Table 1. Patient characteristics
 










years, mean SDa 
 
(range 30-88) 
  0.066 
Sex (M/F) 
n 
121/67 61/33 60/34 0.879 
BMIb  
Kg/m2, mean SD 
 
(range 16.5-42) 
  0.178 
Previous abdominal 
surgery, n 
32 18 14 0.438 
ASAc score, n  0.474 
I 18 11 7 
II 101 52 49 
III 68 31 37 
IV 1 0 1 
Cancer location, n  0.813 
Caecum 56 27 29 
Ascending colon 112 58 54 
Hepatic flexure 20 9 11 
Staged, n  0.560 
I 23 13 10 
II 108 56 52 
III 54 23 31 
IV 3 2 1 









min, mean SDa 
 
[range 85-330] 
 207.47 44.93 <0.05 
Length of stay 










n, mean SD 
0 0 0 1 
Passage of flatus 
days, mean SD 
 
[range 1-7] 
 0.7 0.178 
Harvested lymph 
nodes 
n, mean SD 
 
[range 12-58] 
  0.567 
Specimen length 
cm, mean SD 
38.43 4.69  
[range 27-64] 




32 15 17 0.784 
Grade I 14 7 7  
Grade II 11 4 7  
Grade III 6 3 3  
Grade IV 0 0 0  
Grade V 1 1 0  
Conversion (n) 3 0 3 0.08 







Cost of instruments 6280  1504  4776   
Cost of operative room 2179   803  575  <0.005 
Cost of length of stay 3143  1435  3292  1123  -146  315  0.475 
Final cost    5380  471  <0.005 
aNumbers are represented as m standard deviation (SD)
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